Perioperative bridging with enoxaparin. Results of the prospective BRAVE registry with 779 patients;Perioperative überbrückende antikoagulation mit enoxaparin. Ergebnisse des prospektiven BRAVE-registers mit 779 patienten

Medizinische Klinik

Volumn 102, Issue 10, 2007, Pages 809-815

  Omran, Heyder ^a   Hammerstingl, Christoph ^a   Paar, W Dieter ^b  

^a ST MARIEN HOSPITAL   (Germany)

^b Medizinische Abteilung   (Germany)

Author keywords

Anticoagulation; Bleeding; Enoxaparin; Low molecular weight heparin; Perioperative therapy; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CREATININE CLEARANCE; DOSE CALCULATION; DOSE KIDNEY FUNCTION RELATION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; REGISTER; THROMBOEMBOLISM; TREATMENT WITHDRAWAL;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FEMALE; HEMORRHAGE; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; SURGICAL PROCEDURES, ELECTIVE; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 35448981549     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-007-1098-0     Document Type: Article

References (34)

1. Dunn A. Perioperative management of oral anticoagulation: when and how to bridge. J Thromb Thrombolysis 2006;21:85-9.
2. Spyropoulos AC. Bridging of oral anticoagulation therapy for invasive procedures. Curr Hematol Rep 2005;4:405-13.
3. Jafri SM. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004;147:3-15.
4. Douketis JD, Crowther MA, Cherian SS, et al. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest 1999;116:1240-6.
5. Bauersachs R, Schellong S, Haas S, et al. Überbrückung der oralen Antikoagulation bei interventionellen Eingriffen. Dtsch Ärztebl 2007;104:A1237-44.
6. Spyropoulos AC, Turpie AG, Dunn AS, et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost 2006;4:1246-52.
7. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2006;48:854-906.
8. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:Suppl:204S-33S.
9. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003;163:901-8.
10. Omran H, Hammerstingl C, Schmidt H, et al. A prospective and randomized comparison of the safety and effects of therapeutic levels of enoxaparin versus unfractionated heparin in chronically anticoagulated patients undergoing elective cardiac catheterization. Thromb Haemost 2003;90:267-71.
11. Greinacher A, Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update. Thromb Res 2006;118:165-76.
12. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:Suppl:429S-56S.
13. Spyropoulos AC, Bauersachs RM, Omran H, et al. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr Med Res Opin 2006;22:1109-22.
14. Katholi RE, Nolan SP, McGuire LB. The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study. Am Heart J 1978;96:163-5.
15. Mehra P, Cottrell DA, Bestgen SC, et al. Management of heparin therapy in the high-risk, chronically anticoagulated, oral surgery patient: a review and a proposed nomogram. J Oral Maxillofac Surg 2000;58:198-202.
16. Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004;110:1658-63.
17. Coresh J, Astor B, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12.
18. Turpie AG, Mason JA. Review of enoxaparin and its clinical applications in venous and arterial thromboembolism. Expert Opin Pharmacother 2002;3:575-98.
19. Lim W, Dentali F, Eikelboom JW, et al. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 2006;144:673-84.
20. Stellbrink C, Nixdorff U, Hofmann T, et al. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation 2004;109:997-1003.
21. Spandorfer JM, Lynch S, Weitz HH, et al. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999;84:478-80, A10.
22. Galla J, Fuhs B. Outpatient anticoagulation protocol for mechanical valve recipients undergoing non-cardiac surgery. J Am Coll Cardiol 2000;35:531A, 1114-64.abstract.
23. Johnson JA, Turpie AG. Temporary discontinuation of oral anticoagulants: role of low molecular weight heparin. Thromb Haemost 2001;85:P2323.
24. Ferreira I, Dos L, Tornos P, et al. Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart 2003; 89:527-30.
25. Omran H, Hammerstingl C, Schmidt H, et al. Periinterventionelles Management bei oral antikoagulierten Patienten. Hämostaseologie 2005;25:L6. abstract.
26. Dunn A, Spyropoulos A, Sirko S, et al. Perioperative bridging therapy with enoxaparin in patients requiring interruption of long term anticoagulant therapy: a multicentre cohort study. Blood 2004;104:abstract 1761.
27. Turpie AG, Douketis J. Enoxaparin is effective and safe as bridging anticoagulation in patients with a mechanical prosthetic heart valve who require temporary interruption of warfarin because of surgery or an invasive procedure. Blood 2004;104:abstract 703.
28. Hammerstingl C, Schlang G, Bernhardt P, et al. Einsetzbarkeit niedermolekularer Heparine bei Umstellung einer oralen Antikoagulation vor Interventionen mit erhöhtem Blutungsrisiko: das "Bonn-Register" - Erfahrungen mit 200 Patienten. Z Kardiol 2004;93:Suppl:281-2.
29. Baudo F, Ghirarduzzi A, Molinatti M, et al. Low molecular weight heparin during surgery in patients on long term oral anticoagulant treatment (OAT): a prospective observational study. Blood 2004; 104:4063.abstract.
30. Halbritter KM, Wawer A, Beyer J, et al. Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes. J Thromb Haemost 2005;3:2823-5.
31. Fanikos J, Tsilimingras K, Kucher N, et al. Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol 2004;93:247-50.
32. Meister W. Die Anwendungsbeobachtung - eine Beobachtung der Anwendung. Dtsch Med Wochenschr 2003;128:859-62.
33. Doig GS, Simpson F. Randomization and allocation concealment: a practical guide for researchers. J Crit Care 2005;20:187-91, discussion 91-3.
34. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.